Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | HCID 59293392 | HCID 59293392 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Diethyl Ether | HCID 3283 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 68457431 | HCID 68457431 | 74% |
Reaction Steps
A solution of 4-(benzyloxy)-1-(1-(2-chloroethyl)-1H-indazol-5-yl)pyridin-2(1H)-one (174 mg, 0.458 mmol) in DMF (2 mL) was treated with piperazine (788 mg, 9.15 mmol), Cs2CO3 (746 mg, 2.29 mmol) and KI (38 mg, 0.23 mmol). After stirring at 50° C. for 16 h, the reaction mixture was diluted with H2O (25 mL) and extracted with EtOAc (3×25 mL). The organics were washed with brine (25 mL), dried (Na2SO4), filtered and concentrated. Purification by flash column chromatography (silica gel, CH2Cl2/MeOH/NH4OH, 30:1:0.1 to 20:1:0.2) provided the free base. This was dissolved in ethyl acetate (0.5 mL) and treated with 1 equivalent of 1 M HCl in Et2O. The resulting mixture was filtered to provide the title compound (157 mg, 74%) as a yellow solid: melting point (mp) 217-218° C. dec; 1H NMR (500 MHz, DMSO-d6) δ 8.80 (s, 1H), 8.17 (s, 1H), 7.81 (d, J=8.8 Hz, 1H), 7.75 (s, 1H), 7.61 (d, J=7.6 Hz, 1H), 7.49-7.41 (m, 4H), 7.40-7.35 (m, 2H), 6.13-6.10 (m, 1H), δ 99 (d, J=2.7 Hz, 1H), 5.15 (s, 2H), 4.79-4.51 (m, 2H), 3.51-3.35 (m, 6H), 3.22-2.98 (m, 4H); ESI MS m/z 430 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08268868B2 |
|---|
| Source dataset | uspto-grants-2012_09 |
|---|
| ORD ID | ord-382a940742d640cca0c138ebb783a6be |
|---|
| Source note | uspto-grants-2012_09 |
|---|